Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Omega 3 Fatty Acid Therapy for Prevention of Vaso-occlusive Crisis and Manifestations in Omani Patients With Sickle Cell Disease

NCT02525107 is registered in ClinicalTrials.gov with Sultan Qaboos University as lead sponsor.

NCT NCT02525107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02525107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Omega 3 Fatty Acid Therapy for Prevention of Vaso-occlusive Crisis and Manifestations in Omani Patients With Sickle Cell Disease
Lead sponsor
Sultan Qaboos University
Phase
Phase 3
Overall status
Unknown status
Start date
September 30, 2015
Completion date
March 31, 2019
Enrollment
280 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease